Functional evaluation of a cell replacement therapy in the inner ear

Area of Science:

• Otolaryngology
• Regenerative Medicine
• Neuroscience

Background:

• Spiral ganglion neuron (SGN) degeneration causes hearing loss.
• Cell replacement therapy offers a potential solution for SGN loss.
• Enhancing implanted cell integration is crucial for therapeutic success.

Purpose of the Study:

• To investigate the effects of chronic electrical stimulation (CES) and neurotrophic growth factor (NGF) on implanted dorsal root ganglion (DRG) neurons.
• To assess the neurite outgrowth and functional integration of transplanted neurons in the inner ear.
• To evaluate the potential of these interventions to improve hearing recovery.

Main Methods:

• 46 guinea pigs received embryonic DRG neuron transplants.
• Treatments included CES and/or NGF administration.
• Electrically evoked auditory brainstem responses (EABRs) were measured.
• Immunohistochemistry was used for cellular analysis.

Main Results:

• Implanted DRG neurons survived in the inner ear for up to 4 weeks.
• CES and/or NGF significantly enhanced neurite projections into the modiolus and spiral ganglion region.
• No significant improvement in EABR thresholds was observed between treated and untreated groups.

Conclusions:

• CES and/or NGF stimulate neurite outgrowth from implanted neurons in the inner ear.
• These interventions did not establish functional connections to the central auditory pathway.
• Further research with extended timelines or novel strategies is needed to achieve functional recovery.